SKAN Group AG (SWX:SKAN)
Switzerland · Delayed Price · Currency is CHF 42.40
-0.60 (-1.40%)
Apr 2, 2026, 5:30 PM CET
SKAN Group AG Market Cap
SKAN Group AG has a market cap or net worth of 953.3 million as of April 2, 2026. Its market cap has decreased by -41.68% in one year.
Market Cap
953.30M
Enterprise Value
1.00B
Revenue
333.34M
Ranking
n/a
PE Ratio
58.58
Stock Price
42.40
Market Cap Chart
Since April 10, 2007, SKAN Group AG's market cap has increased from 47.48M to 953.30M, an increase of 1,907.60%. That is a compound annual growth rate of 17.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 966.79M | -18.56% |
| Dec 30, 2025 | 1.19B | -30.71% |
| Dec 30, 2024 | 1.71B | -5.69% |
| Dec 29, 2023 | 1.82B | 28.25% |
| Dec 30, 2022 | 1.42B | -28.89% |
| Dec 30, 2021 | 1.99B | 1,168.29% |
| Dec 29, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 251.71B |
| Novartis AG | 230.62B |
| Lonza Group AG | 36.10B |
| Galderma Group AG | 35.98B |
| Cosmo Pharmaceuticals | 1.40B |
| Aevis Victoria | 1.07B |
| Medartis Holding AG | 954.82M |
| PolyPeptide Group AG | 935.74M |